STAA Stock Analysis: Buy, Sell, or Hold?
STAA - Staar Surgical Co
$27.79
-0.36 (-1.28%)
▼
5d:
-10.96%
30d:
-2.46%
90d:
+43.77%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When STAA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: STAA is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: STAA is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$48.08
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$29.85
6.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STAA is currently trading at $27.79, which is considered oversold relative to its 30-day fair value range of $28.21 to $30.49. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.1) compared to its historical average (41.8). Remarkably, the market is currently pricing in an annual earnings decline of 12.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, STAA is in a strong uptrend. The price is currently testing key support at $27.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STAA is in a strong uptrend. The price is currently testing key support at $27.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$28.21 -
$30.49
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.6%
Protect Your Profits
Holding STAA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($29.67)
- WARNING: Recommendation downgraded due to -11.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$28.21 -
$30.49
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$2.24
(8.1%)
Support & Resistance Levels
Support Level
$27.47
Resistance Level
$31.30
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.14
Wall Street Target
$29.67
(+6.8%)
Revenue Growth (YoY)
119.6%
Earnings Growth (YoY)
-10.5%
Profit Margin
-7.2%
Valuation Discount vs History
-12.3% cheaper
PE vs Historical
28.1 vs 41.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-12.3%
(market-implied from PE analysis)
1-Year Target
$25.01
(-10%)
2-Year Target
$22.51
(-19%)
3-Year Target
$20.26
(-27%)
3-Yr Target (if PE normalizes)
(PE: 28→42)
$30.09
(+8%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.1, Growth: 34.1%)
$67.04
(+141%)
Base:
(SPY PE: 21.8, Growth: 34.1%)
$51.89
(+87%)
Bear:
(PE: 18.5, Growth: 34.1%)
$44.10
(+59%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.1 to 41.8
Stabilization Target:
$41.28
(+48.5%)
PE Expansion Potential:
+48.5%
Share & Embed Analysis
Last updated: July 04, 2026 12:14 PM ET
Data refreshes hourly during market hours. Next update: 1:14 PM
Data refreshes hourly during market hours. Next update: 1:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STAA showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Broadwood Partners, L.P.
BUY
316017 shares
2026-03-13
Broadwood Partners, L.P.
BUY
299432 shares
2026-03-12
Broadwood Partners, L.P.
BUY
54764 shares
2026-03-11
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
Advanced STAA Option Strategies
Professional options setups generated by AI based on today's STAA price and gamma walls.
